Abstract:ABSTRACT The emergence of antibiotic-resistant pathogenic bacteria within the last decades is one reason for the urgent need for new antibacterial agents. A strategy to discover new anti-infective compounds is the evaluation of the genetic capacity of secondary metabolite producers and the activation of cryptic gene clusters (genome mining). One genus known for its potential to synthesize medically important products is Amycolatopsis . However, Amycolatopsis japonicum does not produce an antibiotic under standard laboratory conditions. In contrast to most Amycolatopsis strains, A. japonicum is genetically tractable with different methods. In order to activate a possible silent glycopeptide cluster, we introduced a gene encoding the transcriptional activator of balhimycin biosynthesis, the bbr gene from Amycolatopsis balhimycina ( bbr Aba ), into A. japonicum . This resulted in the production of an antibiotically active compound. Following whole-genome sequencing of A. japonicum , 29 cryptic gene clusters were identified by genome mining. One of these gene clusters is a putative glycopeptide biosynthesis gene cluster. Using bioinformatic tools, ristomycin (syn. ristocetin), a type III glycopeptide, which has antibacterial activity and which is used for the diagnosis of von Willebrand disease and Bernard-Soulier syndrome, was deduced as a possible product of the gene cluster. Chemical analyses by high-performance liquid chromatography and mass spectrometry (HPLC-MS), tandem mass spectrometry (MS/MS), and nuclear magnetic resonance (NMR) spectroscopy confirmed the in silico prediction that the recombinant A. japonicum /pRM4- bbr Aba synthesizes ristomycin A.

Disruption of a Methyltransferase Gene in Actinomycin G Gene Cluster in Streptomyces Iakyrus Increases the Production of Phenazinomycin.

Identification and characterization of the actinomycin G gene cluster in Streptomyces iakyrus.

Identification of the Actinomycin D Biosynthetic Pathway from Marine-Derived Streptomyces costaricanus SCSIO ZS0073

Genome Mining Enabled by Biosynthetic Characterization Uncovers a Class of Benzoxazolinate‐Containing Natural Products in Diverse Bacteria

Cycloheximide and Actiphenol Production in Streptomyces Sp Yim56141 Governed by Single Biosynthetic Machinery Featuring an Acyltransferase-Less Type I Polyketide Synthase

Mutasynthesis of Antibacterial Halogenated Actinomycin Analogues

Characterization of the Glycosyltransferase and Methyltransferase Encoded Remotely from the Actinopyrone Biosynthetic Gene Cluster Enables Access to Diverse Analogues.

Activation of a silent phenazine biosynthetic gene cluster reveals a novel natural product and a new resistance mechanism against phenazines

Subtilisin-Involved Morphology Engineering for Improved Antibiotic Production in Actinomycetes.

Deciphering pactamycin biosynthesis and engineered production of new pactamycin analogues

Characterization of the Azinomycin B Biosynthetic Gene Cluster Revealing a Different Iterative Type I Polyketide Synthase for Naphthoate Biosynthesis

Characterization Of Biosynthetic Genes Of Ascamycin/Dealanylascamycin Featuring A 5 '-O-Sulfonamide Moiety In Streptomyces Sp. Jcm9888

Mutational Analysis of A Phenazine Biosynthetic Gene Cluster in Streptomyces Anulatus 9663

Overproduction of Ristomycin A by Activation of a Silent Gene Cluster in Amycolatopsis japonicum MG417-CF17

The Biosynthetic Gene Cluster of Pyrazomycin-A C-Nucleoside Antibiotic with a Rare Pyrazole Moiety

A New Actinomycin Z Analogue with an Additional Oxygen Bridge Between Chromophore and Β-Depsipentapeptide from Streptomyces Sp. KIB-H714

Discovery of actinomycin L, a new member of the actinomycin family of antibiotics

Activation of Anthrachamycin Biosynthesis in Streptomyces Chattanoogensis L10 by Site-Directed Mutagenesis of Rpob

ActO, a positive cluster-situated regulator for actinomycins biosynthesis in Streptomyces antibioticus ZS

Overproduction of lactimidomycin by cross-overexpression of genes encoding Streptomyces antibiotic regulatory proteins

Identification of the Biosynthetic Gene Cluster of Thermoactinoamides and Discovery of New Congeners by Integrated Genome Mining and MS-Based Molecular Networking